Safiullah Syed, MD
Psychiatry · Beckley, WVNPI 1376629592
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $574 of the $784 with a category attached, or 73.3%. 5 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 58.0% of the total.
Across 61 payments — averaging $12.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$455
- AbbVie$281
- Sunovion Pharmaceuticals Inc.$25
- Corium, LLC$12
- Supernus Pharmaceuticals, Inc.$11
What the payments were for
- Food & beverage$57473%
- Education$20927%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 29 | $455 |
| AbbVie(2 entities) | 28 | $281 |
| Sunovion Pharmaceuticals Inc. | 2 | $25 |
| Corium, LLC | 1 | $12 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$784 in reported general payments places this provider in the 70th percentile of 177 psychiatry providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuedextaDextromethorphan Hbr/Quinidine | 17 | $25,557 |
| Aripiprazole | 125 | $2,714 |
| Lorazepam | 267 | $2,644 |
| Paroxetine Hcl | 124 | $2,547 |
| Memantine Hcl | 100 | $2,289 |
| Chlorpromazine Hcl | 15 | $2,259 |
| Duloxetine Hcl | 147 | $2,173 |
| Risperidone | 99 | $1,819 |
| Buspirone Hcl | 140 | $1,759 |
| Donepezil Hcl | 121 | $1,746 |
| Divalproex Sodium | 85 | $1,711 |
| Quetiapine Fumarate | 153 | $1,605 |
| Clonazepam | 172 | $1,442 |
| Bupropion XlBupropion Hcl | 122 | $1,398 |
| Bupropion Hcl SrBupropion Hcl | 78 | $1,315 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Beckley
- Ahmed FaheemBeckley$82K
- Hassan JafaryBeckley$18K
- Jawad ZafarBeckley$15K
- Omar HasanBeckley$5K
- Melissa MoodyCharleston$1.2M
- April BaisdenScott Depot$775K
- Ryan WakimWheeling$772K
- Daniel ThistlethwaiteSouth Charleston$468K
- Walter ByrdMorgantown$299K
- Fahd MousaCharleston$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.